Assessing the safety, impact and effectiveness of RTS,S/AS01E malaria vaccine following its introduction in three sub-Saharan African countries: methodological approaches and study set-up

Assessing the safety, impact and effectiveness of RTS,S/AS01E malaria vaccine following its introduction in three sub-Saharan African countries: methodological approaches and study set-up

Abstract Background Following a 30-year development process, RTS,S/AS01 E (GSK, Belgium) is the first malaria vaccine to reach Phase IV assessments. The World Health Organization-commissioned Malaria Vaccine Implementation Programme (MVIP) is coordinating the delivery of RTS,S/AS01 E through routine...

全面介紹

Saved in:
書目詳細資料
Main Authors: Nicolas Praet, Kwaku Poku Asante, Marie‐Cécile Bozonnat, Elaine Jacqueline Akité, Patrick Ansah, Laurence Baril, Owusu Boahen, Yolanda Guerra Mendoza, Valérie Haine, Simon Kariuki, Mathieu Lamy, Kenneth Maleta, Randy G. Mungwira, Latif Ndeketa, Abraham Oduro, Bernhards Ogutu, Fredrick Olewe, Martina Oneko, Mattéa Orsini, François Roman, Édith Roset Bahmanyar, Dominique Rosillon, Lode Schuerman, Valentine Sing’oei, Dianne J. Terlouw, Stéphanie Wéry, Walter Otieno, Jean‐Yves Pirçon
格式: Artigo
語言:英语
出版: 2022
在線閱讀:https://doi.org/10.1186/s12936-022-04144-3
https://malariajournal.biomedcentral.com/track/pdf/10.1186/s12936-022-04144-3
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

因特網

https://doi.org/10.1186/s12936-022-04144-3
https://malariajournal.biomedcentral.com/track/pdf/10.1186/s12936-022-04144-3

相似書籍